» Articles » PMID: 38999972

Biochemical and Histological Differences Between Longitudinal and Vertical Fibres of Dupuytren's Palmar Aponeurosis and Innovative Clinical Implications

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jul 13
PMID 38999972
Authors
Affiliations
Soon will be listed here.
Abstract

Dupuytren's disease, a chronic and progressive fibroproliferative lesion of the hand, which affects the palmar fascia, has a recurrence rate after selective aponeurotomy of 20-40% at 5 years. This study focused, for the first time, on the microanatomical and histopathological characteristics of the longitudinal and vertical fibres (usually spared during surgery) in the aponeurosis with Dupuytren's disease, in different stages of the Tubiana's classification. Twelve human samples were collected and analysed by immunostaining, Total Collagen Assay, ELISA Immunoassay, and immunoblotting for the Von Willebrand factor, α-Sma, D2-40, CD-68, Total Collagen, Collagen-I and III, IL1β, TNF-α to analyse the blood and lymphatic vascularization, the amount and distribution of collagen, and the inflammation. The results show a progressive increase in the arterial vascularization in the vertical fibres (from 8.8/mm in the early stage to 21.4/mm in stage 3/4), and a parallel progressive decrease in the lymphatic drainage (from 6.2/mm to 2.8/mm), correlated with a local inflammatory context (increase in IL-1β and TNF-α until the stage 2) in both the longitudinal and vertical fibres. The acute inflammation after stage 2 decreased, in favour of a fibrotic action, with the clear synthesis of new collagen (up to ~83 µg/mg), especially Collagen-I. These results clearly demonstrate the involvement of the septa of Legueu and Juvara in the disease pathology and the modifications with the disease's progression. A greater understanding of the pathology becomes fundamental for staging and the adequate therapeutic timing, to obtain the best morpho-functional result and the lowest risk of complications.

Citing Articles

The Impact of Sciatic Nerve Injury on Extracellular Matrix of Lower Limb Muscle and Thoracolumbar Fascia: An Observational Study.

Zhao X, Fede C, Petrelli L, Pirri C, Stocco E, Fan C Int J Mol Sci. 2024; 25(16).

PMID: 39201630 PMC: 11354760. DOI: 10.3390/ijms25168945.

References
1.
Ziegler M, Staben A, Lem M, Pham J, Alaniz L, Halaseh F . Targeting Myofibroblasts as a Treatment Modality for Dupuytren Disease. J Hand Surg Am. 2023; 48(9):914-922. DOI: 10.1016/j.jhsa.2023.06.007. View

2.
Henry M . Dupuytren's disease: current state of the art. Hand (N Y). 2014; 9(1):1-8. PMC: 3928378. DOI: 10.1007/s11552-013-9563-0. View

3.
Layton T, Nanchahal J . Recent advances in the understanding of Dupuytren's disease. F1000Res. 2019; 8. PMC: 6396840. DOI: 10.12688/f1000research.17779.1. View

4.
Layton T, Williams L, Nanchahal J . Dupuytren's disease: a localised and accessible human fibrotic disorder. Trends Mol Med. 2022; 29(3):218-227. DOI: 10.1016/j.molmed.2022.12.001. View

5.
Wang M, Rajpar I, Ruggiero N, Fertala J, Steplewski A, Beredjiklian P . Circulating inflammatory cytokines alter transcriptional activity within fibrotic tissue of Dupuytren's disease patients. J Orthop Res. 2021; 40(3):738-749. DOI: 10.1002/jor.25059. View